A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults.
Saved in:
| Title: | A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. |
|---|---|
| Authors: | Kao CM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Rostad CA; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Nolan LE; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Peters E; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Kleinhenz J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Sherman JD; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Tippett A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Shih JWK; Xiamen Innovax Biotech Company Limited, Xiamen, China., Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Agbakoba V; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Beresnev T; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ballou C; The Emmes Company, LLC, Rockville, Maryland, USA., Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Karmali V; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Natrajan M; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Scherer EM; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Rouphael N; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. 1093-1101. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38536442 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kao+CM%22">Kao CM</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Rostad+CA%22">Rostad CA</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Nolan+LE%22">Nolan LE</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Peters+E%22">Peters E</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Kleinhenz+J%22">Kleinhenz J</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Sherman+JD%22">Sherman JD</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Tippett+A%22">Tippett A</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Shih+JWK%22">Shih JWK</searchLink>; Xiamen Innovax Biotech Company Limited, Xiamen, China.<br /><searchLink fieldCode="AU" term="%22Yildirim+I%22">Yildirim I</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Agbakoba+V%22">Agbakoba V</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Beresnev+T%22">Beresnev T</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ballou+C%22">Ballou C</searchLink>; The Emmes Company, LLC, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kamidani+S%22">Kamidani S</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Karmali+V%22">Karmali V</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Natrajan+M%22">Natrajan M</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Scherer+EM%22">Scherer EM</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Rouphael+N%22">Rouphael N</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+EJ%22">Anderson EJ</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. 1093-1101. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38536442 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiae148 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1093 Titles: – TitleFull: A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kao CM – PersonEntity: Name: NameFull: Rostad CA – PersonEntity: Name: NameFull: Nolan LE – PersonEntity: Name: NameFull: Peters E – PersonEntity: Name: NameFull: Kleinhenz J – PersonEntity: Name: NameFull: Sherman JD – PersonEntity: Name: NameFull: Tippett A – PersonEntity: Name: NameFull: Shih JWK – PersonEntity: Name: NameFull: Yildirim I – PersonEntity: Name: NameFull: Agbakoba V – PersonEntity: Name: NameFull: Beresnev T – PersonEntity: Name: NameFull: Ballou C – PersonEntity: Name: NameFull: Kamidani S – PersonEntity: Name: NameFull: Karmali V – PersonEntity: Name: NameFull: Natrajan M – PersonEntity: Name: NameFull: Scherer EM – PersonEntity: Name: NameFull: Rouphael N – PersonEntity: Name: NameFull: Anderson EJ IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2024 Nov 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 230 – Type: issue Value: 5 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |
